References
- Isaacson P G, Norton A J. Extranodal lymphomas. Churchill Livingstone, Edinburgh 1994; 15–16
- Pickhardt P J, Levy A D, Rohrmann C A, Jr, Abbondanzo S L, Kende A I. Non-Hodgkin's lymphoma of the appendix: clinical and CT findings with pathologic correlation. AJR Am J Roentgenol 2002; 178: 1123–1127
- Chang C C, Rowe J J, Hawkins P, Sadeghi E M. Mantle cell lymphoma of the hard palate: a case report and review of the differential diagnosis based on the histomorphology and immunophenotyping pattern. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 316–320
- Muller G, Dargent J L, Duwel V, D'Olne D, Vanvuchelen J, Haot J, et al. Leukaemia and lymphoma of the appendix presenting as acute appendicitis or acute abdomen. Four case reports with a review of the literature. J Cancer Res Clin Oncol 1997; 123: 560–564
- Lyman M D, Neuhauser T S. Precursor T-cell acute lymphoblastic leukemia/lymphoma involving the uterine cervix, myometrium, endometrium, and appendix. Ann Diagn Pathol 2002; 6: 125–158
- Kitamura Y, Ohta T, Terada T. Primary T-cell non-Hodgkin's malignant lymphoma of the appendix. Pathol Int 2000; 50: 313–317
- Tsujimura H, Takagi T, Tamaru J, Sakai C. Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma. Leuk Lymphoma 2000; 37: 633–634
- Tan L HC. Lymphomas involving Waldeyer's ring: placement, paradigms, peculiarities, pitfalls, patterns and postulates. Ann Acad Med Singapore 2004; 33(Suppl)15S–26S
- Tsang W M, Tong A C, Lam K Y, Tideman H. Nasal T/NK cell lymphoma: report of 3 cases involving the palate. J Oral Maxillofac Surg 2000; 58: 1323–1327
- Swerdlow S H, Berger F, Isaacson P G, Müller-Hermelink H K, Nathwani B N, Piris M A, . Mantle cell lymphoma. World Heath Organization classification of tumors. pathology and genetics. Tumors of haematopoietic and lymphoid tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman, et al. IARC Press, Lyon 2001; 168–170
- Hagemeister F B. Mantle cell lymphoma: non-myeloablative versus dose-intensive therapy. Leuk Lymphoma 2003; 44(Suppl 3)S69–S75
- Hiddemann W, Dreyling M. Mantle cell lymphoma: therapeutic strategies are different from CLL. Curr Treat Options Oncol 2003; 4: 219–226
- Ott G, Kalla J, Hanke A, Muller J G, Rosenwald A, Katzenberger T, et al. The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. Leuk Lymphoma 1998; 32: 55–63
- Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado M A, et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87: 3351–3359
- Louie D C, Offit K, Jaslow R, Parsa N Z, Murty V V, Schluger A, et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 1995; 86: 2892–2899
- Tiemann M, Schrader C, Klapper W, Dreyling M H, Campo E, Norton A, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 2005; 131: 29–38
- Hashimoto Y, Nakamura N, Kuze T, Abe M. The evaluation of the biological behavior and grade among cases with mantle cell lymphoma. Leuk Lymphoma 2002; 43: 523–530
- Hans C P, Weisenburger D D, Greiner T C, Gascoyne R D, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275–282